Nestlé to Acquire Pfizers Infant Nutrition Unit for $11.9 Billion

VEVEY, SwitzerlandNestlé S.A. finalized a deal to acquire Pfizer's infant nutrition business for $11.85 billion, a move that will bolster Nestlés position in global infant nutrition, especially in emerging markets with fast-growing populations. The acquisition, subject to regulatory approval, is estimated to add $2.4 billion in 2012 sales.

Pfizer Nutrition complements Nestlés existing portfolio with strong brands in key segments and geographies. It will enhance the companys infant nutrition business, building on growth-focused strategy, global presence and pioneering research and development. Nestlé will be able to combine well-known brands like S-26 Gold, SMA and Promil with our existing portfolio of trusted and successful brands such as Nan, Gerber, Lactogen, Nestogen and Cerelac infant cereal.

Infant nutrition has been at the heart of our company since it was founded in 1866. Pfizer Nutrition is an excellent strategic fit and this acquisition underlines our commitment to be the worlds leading nutrition, health and wellness company," said Nestlé CEO Paul Bulcke. Its strong brands and product portfolio, its talented people dedicated to the success of its business, together with its geographic presence85% of its sales are in emerging marketswill complement our existing infant nutrition business perfectly. The combined entities will enable us to deepen our engagement with consumers, offering them a wider choice of nutritious food to ensure their children make a healthy start to a healthy life."